These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 3743615

  • 1. Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.
    van Baak MA, Verstappen FT, Oosterhuis B.
    Eur J Clin Pharmacol; 1986; 30(4):399-406. PubMed ID: 3743615
    [Abstract] [Full Text] [Related]

  • 2. Exercise capacity, energy metabolism, and beta-adrenoceptor blockade. Comparison between a beta 1-selective and a non-selective beta blocker.
    Verstappen FT, van Baak MA.
    Eur J Appl Physiol Occup Physiol; 1987; 56(6):712-8. PubMed ID: 2890520
    [Abstract] [Full Text] [Related]

  • 3. An interactive computer program for randomization analysis of response curves with facilities for multiple comparisons.
    Tan ES, Roos JM, Volovics A, Van Baak MA, Does RJ.
    Comput Biomed Res; 1992 Apr; 25(2):101-16. PubMed ID: 1582188
    [Abstract] [Full Text] [Related]

  • 4. Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily.
    Müller FB, Allsopp LF, Cooper GL, Bolli P, Frei P, Glaus L, Ritz R, Bühler FR.
    Br J Clin Pharmacol; 1985 Apr; 19 Suppl 2(Suppl 2):207S-212S. PubMed ID: 4005124
    [Abstract] [Full Text] [Related]

  • 5. A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers.
    Woods KL, Jack DB, Kendall MJ, Halsey A, O'Donnell ML, Warrington SJ, John VA.
    Br J Clin Pharmacol; 1985 Apr; 19 Suppl 2(Suppl 2):177S-184S. PubMed ID: 4005120
    [Abstract] [Full Text] [Related]

  • 6. Exercise tolerance with nebivolol and atenolol.
    Van Bortel LM, van Baak MA.
    Cardiovasc Drugs Ther; 1992 Jun; 6(3):239-47. PubMed ID: 1353367
    [Abstract] [Full Text] [Related]

  • 7. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG, Brown HC, Carruthers SG, Shanks RG.
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension.
    McInnes GT, Brodie MJ.
    Eur J Clin Pharmacol; 1988 May; 34(6):605-11. PubMed ID: 3169112
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.
    Wilcox RG, Hampton JR.
    Br Heart J; 1981 Nov; 46(5):498-502. PubMed ID: 6119103
    [Abstract] [Full Text] [Related]

  • 10. Effect of calcium channel blockade and beta-adrenoceptor blockade on short graded and single-level endurance exercises in normal men.
    Vanhees L, Fagard R, Amery A.
    Eur J Appl Physiol Occup Physiol; 1988 Nov; 58(1-2):87-91. PubMed ID: 2904883
    [Abstract] [Full Text] [Related]

  • 11. Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.
    Bennett PN, Bennett J, Bradbrook I, Francis J, John VA, Rogers H, Turner P, Warrington SJ.
    Br J Clin Pharmacol; 1985 Nov; 19 Suppl 2(Suppl 2):171S-175S. PubMed ID: 4005119
    [Abstract] [Full Text] [Related]

  • 12. Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy volunteers.
    Moppert J, Degen PH, Racine-Poon A.
    Br J Clin Pharmacol; 1985 Nov; 19 Suppl 2(Suppl 2):197S-201S. PubMed ID: 2988591
    [Abstract] [Full Text] [Related]

  • 13. Effect of beta 1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension.
    Kaiser P, Hylander B, Eliasson K, Kaijser L.
    Am J Cardiol; 1985 Apr 26; 55(10):79D-84D. PubMed ID: 3993553
    [Abstract] [Full Text] [Related]

  • 14. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
    Floris B, Paoletti G, Pelizza L, Bertulla A, Motolese M.
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr 26; 29(4):139-43. PubMed ID: 1906434
    [Abstract] [Full Text] [Related]

  • 15. The effects of antihypertensive medications on the physiological response to maximal exercise testing.
    Derman WE, Sims R, Noakes TD.
    J Cardiovasc Pharmacol; 1992 Apr 26; 19 Suppl 5():S122-7. PubMed ID: 1381788
    [Abstract] [Full Text] [Related]

  • 16. Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade: implications for the prescription of exercise.
    Wilmore JH, Freund BJ, Joyner MJ, Hetrick GA, Hartzell AA, Strother RT, Ewy GA, Faris WE.
    Am J Cardiol; 1985 Apr 26; 55(10):135D-141D. PubMed ID: 3993545
    [Abstract] [Full Text] [Related]

  • 17. Effects of beta 1-selective and nonselective beta-adrenoceptor blockade during exercise conditioning in healthy adults.
    McLeod AA, Kraus WE, Williams RS.
    Am J Cardiol; 1984 Jun 01; 53(11):1656-61. PubMed ID: 6375340
    [Abstract] [Full Text] [Related]

  • 18. Cardiorespiratory alterations consequent to endurance exercise training during chronic beta-adrenergic blockade with atenolol and propranolol.
    Wilmore JH, Ewy GA, Freund BJ, Hartzell AA, Jilka SM, Joyner MJ, Todd CA, Kinzer SM, Pepin EB.
    Am J Cardiol; 1985 Apr 26; 55(10):142D-148D. PubMed ID: 3993546
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.